Home » Topics » Regulatory » Patents

Patents
RSS

Merck investigators discover new glucagon antagonists

Aug. 20, 1998

More PDE4 inhibitors described by Byk Gulden

Aug. 20, 1998

Kissei reports more new agents for treating diabetic complications

Aug. 20, 1998

Novel signal transduction inhibitors reported by Zeneca

Aug. 19, 1998

Medivir synthesizes esters of antiviral nucleosides with improved bioavailability

Aug. 19, 1998

Akzo Nobel claims antipsychotic piperidine derivatives

Aug. 19, 1998

Selective beta3-adrenergic agents reported in development at Tokyo Tanabe

Aug. 19, 1998

Kanebo reveals new immunosuppressants in the pipeline

Aug. 19, 1998

Antifungal agents disclosed by Sankyo in patent literature

Aug. 19, 1998

Kotobuki also conducting research on COX-2 inhibitors

Aug. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...